Cargando…
HIPK2 as a Novel Regulator of Fibrosis
SIMPLE SUMMARY: Fibrosis can affect almost every organ and represents an increasing cause of morbidity and mortality worldwide. Despite significant progress in our understanding of the pathobiology of fibrosis, there is still a lack of putative anti-fibrotic targets to be exploited in anti-fibrosis...
Autores principales: | Garufi, Alessia, Pistritto, Giuseppa, D’Orazi, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954661/ https://www.ncbi.nlm.nih.gov/pubmed/36831402 http://dx.doi.org/10.3390/cancers15041059 |
Ejemplares similares
-
The Sweet Side of HIPK2
por: Garufi, Alessia, et al.
Publicado: (2023) -
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
por: Garufi, Alessia, et al.
Publicado: (2023) -
Hyperglycemia triggers HIPK2 protein degradation
por: Baldari, Silvia, et al.
Publicado: (2016) -
Targeting COX-2/PGE(2) Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation
por: Garufi, Alessia, et al.
Publicado: (2012) -
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
por: Garufi, Alessia, et al.
Publicado: (2022)